FINWIRES · TerminalLIVE
FINWIRES

Amer Sports' Raised Q3 Outlook Supports Fiscal 2026 Estimates, UBS Says

By

Amer Sports' (AS) updated Q3 guidance and long-term financial targets reinforce the company's growth trajectory, with the higher near-term outlook supporting fiscal 2026 estimates, UBS Securities said in a Wednesday note.

Management now expects Q3 revenue growth of 20% to 22%, up from 18% to 20%. UBS estimates Q3 earnings per share of $0.34 to $0.36 versus the $0.33 consensus and said the Street's $1.29 fiscal 2026 EPS estimate could rise by $0.01 to $0.03.

For the long term, Amer targets low-double-digit to mid-teens revenue growth for at least five years after fiscal 2026, with fiscal 2031 EPS of about $3.25, plus or minus $0.50. UBS forecasts fiscal 2026 revenue of $8.19 billion and EPS of $1.30, the report said.

The bank noted that the higher Q3 outlook strengthens Amer's long-term financial outlook, while the company also raised growth expectations for its Outdoor Performance and Ball & Racquet segments.

UBS maintained its buy rating on the stock with a price target of $62.

Amer Sports shares were down 2.1% in Thursday trading.

Price: $26.51, Change: $-0.62, Percent Change: -2.29%

What else is happening in Wire?

Wire

Halozyme Therapeutics Plans $1.05 Billion Offering of Convertible Notes

Halozyme Therapeutics (HALO) plans to launch an offering of $1.05 billion of convertible senior notes due 2033, subject to market conditions.Initial purchasers will have a 13-day option to buy up to an additional $150 million of the notes, the company said Wednesday in a statement.Halozyme expects to use part of the proceeds to fund capped call transactions and to enter agreements with holders of its 0.25% convertible notes due 2027 and 1% convertible notes due 2028 to repurchase their notes for cash. The remainder will be used for general corporate purposes.Halozyme shares fell 1.8% in after-hours trading.

$HALO
Wire

Medical Properties Trust Completes Sale of 2 Idaho Hospitals

Medical Properties Trust (MPT) completed the sale of two Idaho hospital properties to affiliates of Intermountain Health for $413 million.The company said Wednesday it received $371 million in cash proceeds for Idaho Falls Community Hospital and Mountain View Hospital with $42 million distributed to minority real-estate owners.The sale represents a gain of about $130 million over the hospitals' gross book value, Medical Properties Trust said.The company expects to use a majority of the proceeds to reduce debt.Medical Properties Trust shares rose 2.1% in after-hours trading.

$MPT
Wire

BCB Bancorp Launches Stock Offering; Identifies Portfolio of Problem Loans; Expects Q3 Net Loss

BCB Bancorp (BCBP) said Wednesday it has launched an underwritten public offering of shares. Net proceeds will be used for general corporate purposes and to support capital, including in connection with the planned disposition of potential problem loans, among other purposes, it said.The company said that the management of its unit BCB Community Bank has identified for sale and started marketing of a portfolio of problem loans.The bank has received indications of interest from potential buyers covering all of the about $210 million principal balance of the problem loans for sale, it said, adding it expects to complete the sales during Q3.In addition, the bank said that during Q3, it plans to transfer about $27 million of commercial real estate loans showing credit weakness to held for sale. The bank also said it started marketing for the potential sale of its business lines focused on cannabis-related clients.The company said it now expects a Q3 provision for credit losses of $112 million to $120 million, and to post a Q3 net loss between $126.2 million and $136.1 million.BCB Bancorp shares were down nearly 8% in after-hours activity.

$BCBP